Risk genes associated with pediatric-Onset MS but not with monophasic acquired CNS demyelination

Neurology

Volumn 81, Issue 23, 2013, Pages 1996-2001

  Danielle van Pelt E ^a   Mescheriakova, Julia Y ^a   Makhani, Nalia ^c   Ketelslegers, Immy A ^a   Neuteboom, Rinze F ^a   Kundu, Suman ^b   Broer, Linda ^b   Janssens, Cecile ^b,d   Catsman Berrevoets, Coriene E ^a   Van Duijn, Cornelia M ^b   Banwell, Brenda ^e   Bar Or, Amit ^f   Hintzen, Rogier Q ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB1 ANTIGEN;

ACQUIRED DEMYELINATING SYNDROME; ADOLESCENT; ALLELE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD; CHILDHOOD DISEASE; CLINICAL PROTOCOL; DEMYELINATION; DNA PURIFICATION; FEMALE; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC RISK; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMYELINATING DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES; HUMANS; MALE; MULTIPLE SCLEROSIS; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84892381360     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436934.40034eb     Document Type: Article

References (27)

1. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007;6: 887-902
2. Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011;10:436-445
3. Neuteboom RF, Boon M, Catsman Berrevoets CE, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008;71:967-973.
4. Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol 2012;11:157-169
5. Disanto G, Magalhaes S, Handel AE, et al. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. Neurology 2011;76:781-786.
6. Ramagopalan SV, Knight JC, Ebers GC. Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol 2009;22:219-225.
7. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214-219
8. De Jager PL, Chibnik LB, Cui J, et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 2009;8:1111-1119.
9. Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68:S7-S12.
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846.
11. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422.
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
13. Johnson AD, Handsaker RE, Pulit S, et al. SNAP: a webbased tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008;24:2938-2939.
14. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166-1172.
15. Field J, Browning SR, Johnson LJ, et al. A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis. PLoS One 2010;5:e13454.
16. Jafari N, Broer L, van Duijn CM, Janssens AC, Hintzen RQ. Perspectives on the use of multiple sclerosis risk genes for prediction. PLoS One 2011;6:e26493.
17. Wallin MT, Page WF, Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004;55:65-71.
18. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5:932-936.
19. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, Group G. Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Med 2011;8:e1000420.
20. The R project for statistical computing [online]. Available at: www.R-project.org. Accessed October 8, 2012
21. Kundu S, Aulchenko YS, van Duijn CM, Janssens AC. PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol 2011;26:261-264.
22. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005;21:3940-3941.
23. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, KannelWB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
24. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009;66:54-59.
25. Mikaeloff Y, Suissa S, Vallee L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246-252
26. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010;6:156-166.
27. Simon KC, van der Mei IA, Munger KL, et al. Combined effects of smoking, anti-EBNA antibodies, and HLADRB1* 1501 on multiple sclerosis risk. Neurology 2010; 74:1365-1371